The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome.

Concerning differences in glucose levels, while a similar reduction in the differential as that for insulin was documented at T3, this reduction did not reach statistical significance (∆ T0: 9.01 ± 1.84 mg/dL vs. ∆ T3: 6.46 ± 1.61 mg/dL; p < 0.544 = NS) ( Figure 1 a,b).

also in 111,027 other papers